Valneva has been awarded funding from the Coalition for Epidemic Preparedness Innovations (CEPI) and EU to expand access to its recently approved vaccine for chikungunya, a potentially life ...

Valneva (VALN) has released an update. Valneva is set to showcase its pioneering chikungunya vaccine, IXCHIQ®, at several esteemed scientific ...

Pfizer Inc. and French partner Valneva SE reported positive results Tuesday from a mid-stage trial of their Lyme disease ...

Saint-Herblain (France), October 21, 2024 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, announces today that members of its senior leadership team will present ...

VALNEVA Declaration of shares and voting rights September 30, 2024_____ Company name: VALNEVARegistered office ...

Valneva SE is a specialty vaccine company, which focuses on the development, manufacturing, and commercialization of prophylactic vaccines for infectious diseases. It operates through the ...

Pfizer And Valneva Partnered Lyme Disease Vaccine Shows Effectiveness As Booster Shot In Mid-Stage Study Valneva and Pfizer released data from their Phase 2 study of the Lyme disease vaccine ...

6 analysts have shared their evaluations of Valneva VALN during the recent three months, expressing a mix of bullish and bearish perspectives. Summarizing their recent assessments, the table below ...

Saint-Herblain (France), October 21, 2024 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, announces today that members of its senior leadership team will present d ...

Saint Herblain (France), October 10, 2024 –Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, is hosting an investor day today in New York City to discuss the Company ...

Valneva (VALN) has released an update. Valneva is set to showcase its pioneering chikungunya vaccine, IXCHIQ®, at several esteemed scientific forums this quarter, highlighting two-year antibody ...

Saint-Herblain (France), October 21, 2024 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, announces today that members of its senior leadership team will present d ...